Navigation Links
Marc Travel Awards announced for the 2012 Biomedical Engineering Society Annual Meeting
Date:9/20/2012

Bethesda, MD FASEB MARC (Minority Access to Research Careers) Program has announced the travel award recipients for the 2012 Biomedical Engineering Society (BMES) Annual Meeting in Atlanta, GA from October 24-27, 2012. These awards are meant to promote the entry of underrepresented minority students, postdoctorates and scientists into the mainstream of the basic science community and to encourage the participation of young scientists at the 2012 BMES Annual Meeting.

Awards are given to poster/platform presenters and faculty mentors paired with the students/trainees they mentor. This year MARC conferred 12 awards totaling $22,200.

The FASEB MARC Program is funded by a grant from the National Institute of General Medical Sciences, National Institutes of Health. A primary goal of the MARC Program is to increase the number and competitiveness of underrepresented minorities engaged in biomedical and behavioral research.


'/>"/>

Contact: Gail Pinder
gpinder@faseb.org
301-634-7021
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. MARC travel awards announced for 2012 American Society for Bone & Mineral Research annual meeting
2. MARC travel awards announced for the 2012 APS Integrative Biology of Exercise meeting
3. MARC travel awards announced for the 2012 SACNAS Annual Meeting
4. Bigger creatures live longer, travel farther for a reason
5. MARC travel awards announced for 2012 Institute on Teaching and Mentoring
6. MARC travel awards announced for Leadership Development and Grant Writing Seminar
7. MARC travel awards announced for the 2012 ECCB/ISCB Conference
8. MARC travel awards announced for the 2012 American Society of Human Genetics Annual Meeting
9. Frequent traveller: Dysentery-causing bacteria spreading from Europe to Australia
10. MARC travel awards announced for the 2012 Society for the Study of Reproduction 45th Annual Meeting
11. MARC Travel Awards announced for 2012 XXXI Congress of the Societa Italiana di Pathologia e Medicina
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):
(Date:5/6/2016)... ... May 06, 2016 , ... Crucial Life Sciences Data Solutions, ... greatly improves performance of the platform. In particular, Version 4.1 boosts performance for ... data to be collected on a per patient basis. Clinical Studio has employed ...
(Date:5/5/2016)... ... May 05, 2016 , ... American Process, Inc. (API) announced ... Patent Nos. 9,322,133 and 9,322,134, to API and its affiliated companies for BioPlus® ... hydrophobic nanocellulose compositions. In addition to these patents and U.S. Patent No. ...
(Date:5/4/2016)... , ... May 05, 2016 , ... ... proud to support the National Stroke Association during National Stroke Awareness Month in ... Facebook and Twitter pages throughout the month. CereScan will donate $1 up ...
(Date:5/4/2016)... WHIPPANY, N.J. , May 4, 2016 /PRNewswire/ ... evaluating its oncology compound Stivarga ® (regorafenib) ... hepatocellular carcinoma (HCC) has met its primary endpoint ... The study, called RESORCE, evaluated the efficacy and ... disease has progressed after treatment with sorafenib. The ...
Breaking Biology Technology: